DS-4824

N/A

Report date: 2022/02/09 10:02:02
NME

Base Information

Drug NameDS-4824
Drug Alias NameDS-4824
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersSodium channel alpha subunit blockers
TargetsPotassium channelSodium channel alpha subunit
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co LtdSanten
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A